Synergistic Biochemical Scaffold Delivery Systems
Legal Citation
Summary of the Inventive Concept
This inventive concept integrates biochemical scaffolds with distinct technologies like AI, IoT, blockchain, and new materials to create more powerful systems for enhancing mental function and acuity.
Background and Problem Solved
The original patent's limitation lies in its lack of real-time monitoring and feedback, as well as limited personalized delivery options. This new concept addresses these limitations by introducing wearable devices with AI-powered brain-computer interfaces, microfluidic delivery systems, and blockchain-secured genomic data.
Detailed Description of the Inventive Concept
The new system comprises a wearable device integrated with AI-powered brain-computer interface technology for real-time monitoring and feedback, and a microfluidic delivery system for precise administration of the biochemical scaffolds. Additionally, machine learning algorithms and blockchain-secured genomic data are used to generate personalized biochemical scaffolds. The system also includes an IoT-enabled network of wearable devices for real-time monitoring and feedback, and a novel material with tunable mechanical properties is used to create customized implantable devices for delivering biochemical scaffolds.
Novelty and Inventive Step
The integration of biochemical scaffolds with AI, IoT, blockchain, and new materials is new and non-obvious, providing a synergistic combination that enhances mental function and acuity in a more efficient and personalized manner.
Alternative Embodiments and Variations
Other embodiments could include using different AI-powered analytics, varying the type of wearable devices, or incorporating additional technologies like augmented reality or 5G networks.
Potential Commercial Applications and Market
This inventive concept has significant commercial potential in the healthcare, wellness, and education industries, with potential applications in personalized medicine, cognitive enhancement, and mental health treatment.
CPC Classifications
| Section | Class | Group |
|---|---|---|
| A | A61 | A61K41/0004 |
| A | A61 | A61K31/197 |
| A | A61 | A61K31/4188 |
| A | A61 | A61K31/4415 |
| A | A61 | A61K31/455 |
| A | A61 | A61K31/51 |
| A | A61 | A61K31/519 |
| A | A61 | A61K31/525 |
| A | A61 | A61K31/661 |
| A | A61 | A61K31/714 |
| A | A61 | A61K36/06 |
| A | A61 | A61K36/23 |
| A | A61 | A61K36/68 |
| A | A61 | A61K36/9068 |
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Biochemical and pharmaceutical technologies focused on neurological enhancement, specifically involving cognitive function improvement through biochemical scaffold delivery systems, with expertise in pharmacological formulations, neuroscience, and biomedical engineering
Person of Ordinary Skill (PHOSITA) Profile
A professional with advanced degrees in biochemistry, neuroscience, or biomedical engineering, possessing knowledge of pharmaceutical formulation techniques, brain-computer interfaces, nanotechnology, and personalized medicine approaches
Obviousness Rationale
A PHOSITA would recognize that integrating advanced technologies like AI, blockchain, and IoT with existing biochemical scaffold delivery methods represents a predictable technological evolution. The source patent establishes a foundational method for mental function enhancement, and the PTD demonstrates logical extensions using known technological integration strategies. The variations represent incremental improvements using standard interdisciplinary engineering approaches that would be obvious to a skilled practitioner in the field.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,626 |
|---|---|
| Title | Method of enhancing mental function and acuity by delivering biochemical scaffolds |
| Assignee(s) | Next2Me, LLC |